1[1]Patt S,Thiel G, Mans S, et al. Chromosomal changs and corresponingly altered proto- oncogene expression in human glioma,value of combined cytogenetic and molecular genetic analysis. Anticancer Res, 1993,13:113.
2[2]Rey JA, Pestana A, Bello MG. Cytogenetics and molecular genetics of nervous system tumors. Oncol Res, 1992,4:321.
3[3]Maier D, zhang Z, Taylor E, et al. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25～26 region as the primary target in low- grade and high - grade gliomas, Oncogene. 1998,16:3331 ～ 3335.
4[4]Lin H, Bondy ML, Lanyford LA, et al. Allelic deletion analyses ofMMAC1/PTN and DMBT1 loci in gliomas: relationship to prognastic significance. Clin Can Res, 1998,4:2447 ～ 2454.
5[5]Bennett M, Macdonald K, Chan SW, et al. Cell surface trafficking of Fas: A rapid mechanism of P53 - mediated apoptosis. Science, 1998,282 (5387): 290.
6[6]Frei K, Ambar B, Adachi N, et al. Ex vivo malignant glioma cells are sensitive to Fas(CD95/APO- 1) Ligand- mediated apoptosis. J Neuroimmunal, 1998,187( 1 - 2): 105.
7[7]Jaye M, Schlessinger J, Craig A, et al. Immunohistochemical localization of basic fibroblast growth factor in astrocytoma. Cancer Reserch, 1990,50: 7393 ～ 7398.
8[8]Plate Klf, Breier G, Weich HA, et al. Vascular endothelial growthfactor and angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanism. Int J Cancer, 1994,59(4) :520.
9[9]Jensen RL. Growth factor- mediated angiogenesis in the malignant progression of glial tumors: a review. Surg Neurol, 1998 ,49:189～ 196.
10[10]Yamamoto M, Sawya R, Mohanam S, et al. Expression and localization of urokinas4 - type plasmioxgen activator in human astrocytomas in vivo. Cancer Res, 1994,54:3656～ 3661.
